At a glance

CDC supports Idaho and other state and local health departments, or their bona fide agents, through cooperative agreements to support childhood lead poisoning prevention activities. Read about the program's success.

Idaho state roadside sign

About the program

The State of Idaho received $300,000 through cooperative agreement EH21-2102 from the Centers for Disease Control and Prevention (CDC) in FY 2022. The funds address childhood lead poisoning prevention and surveillance programmatic activities conducted during September 30, 2022, to September 29, 2023.

The strategies focus on:

  • Ensuring blood lead testing and reporting
  • Enhancing blood lead surveillance
  • Improving linkages to recommended services

To learn more about these efforts in Idaho, contact the program below.

Idaho Department of Health and Welfare

450 West State Street, 10th Floor

Boise, ID 83702

Phone: 208-334-0641

Success story: funding year 2

Building partnerships in Idaho to create a successful program


In September 2021, the Idaho Department of Health and Welfare, Division of Public Health, was awarded funding from CDC. The funding enabled Idaho to create their first Childhood Lead Poisoning Prevention Program (CLPPP). The CLPPP was housed within the Environmental Health Program (EHP). EHP was tasked with establishing a successful program to raise awareness about childhood lead exposures, identify populations at higher risk for lead exposure, and improve blood lead level (BLL) testing rates and case management for children with higher BLLs.


In November 2021, EHP began forming partnerships to ensure a comprehensive program was developed. EHP wanted their program to cover all populations affected by lead exposure in Idaho. The partnerships included established CLPPPs in neighboring states: California, Montana, Oregon, Utah, and Washington. Over the next eight months, meetings were held to discuss topics such as how the states were implementing their programs, challenges and successes of their programs, education and outreach efforts, and how each program collects and reports blood lead testing data.


Receiving perspectives from different states has been invaluable for shaping how EHP moves forward with developing Idaho's first CLPPP. For example, Idaho is in the process of adapting their blood lead surveillance system to meet CDC reporting requirements. During the meetings, other states provided insight on what additional data fields the program should expand on or include to enhance the surveillance system. In addition, partners have shared training and educational materials to encourage consistent messaging and opportunities to collaborate and expand existing materials.

Funding for this work was made possible in part by NUE2EH001428 from the Centers for Disease Control and Prevention (CDC). The views expressed in this material do not necessarily reflect the official policies of the CDC; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.